Abstract 1308: <i>CDK12</i> alterations define a distinct molecular subtype of prostate cancers with unique genomic and clinical characteristics

Authors: Bastien Nguyen, Jose Mauricio Mota, Subhiksha Nandakumar, Konrad H. Stopsack, Emily Weg, Dana Rathkopf, Michael J. Morris, Howard Scher, Philip W. Kantoff, Anuradha Gopalan, Dmitriy Zamarin, David B. Solit, Nikolaus Schultz, Wassim Abida

Published: 2020-09-04

DOI: 10.1158/1538-7445.am2020-1308

Source: Full article